T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
MasTec
MTZ
$23B
| $676K | ﹤0.01% |
35,000
+9,200
| +36% | +$184K |
|
1852
CACI
CACI
$14.8B
| $674K | ﹤0.01% |
7,500
-1,200
| -14% | -$105K |
|
1853
Trustmark
TRMK
$2.8B
| $674K | ﹤0.01% |
27,749
+3,800
| +16% | +$88.2K |
|
1854
Blackbaud
BLKB
$2.1B
| $673K | ﹤0.01% |
14,200
| – | – |
|
|
OVTI
1855
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $672K | ﹤0.01% |
25,481
+4,220
| +20% | +$113K |
|
1856
DNOW Inc
DNOW
$2.95B
| $669K | ﹤0.01% |
30,921
-630
| -2% | -$14.7K |
|
|
AEL
1857
DELISTED
American Equity Investment Life Holding Company
AEL
| $667K | ﹤0.01% |
22,900
| – | – |
|
1858
Insight Enterprises
NSIT
$4.6B
| $666K | ﹤0.01% |
23,350
+4,000
| +21% | +$103K |
|
|
CNW
1859
DELISTED
CON-WAY INC.
CNW
| $666K | ﹤0.01% |
15,100
+2,000
| +15% | +$88.3K |
|
1860
California Water Service
CWT
$3.1B
| $663K | ﹤0.01% |
27,062
+6,727
| +33% | +$166K |
|
|
AHL
1861
DELISTED
ASPEN Insurance Holding Limited
AHL
| $661K | ﹤0.01% |
14,000
| – | – |
|
|
ESSA
1862
DELISTED
ESSA Bancorp
ESSA
| $653K | ﹤0.01% |
50,900
| – | – |
|
1863
Interactive Brokers
IBKR
$41.4B
| $646K | ﹤0.01% |
76,000
| – | – |
|
|
HRC
1864
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $644K | ﹤0.01% |
13,150
| – | – |
|
1865
BCE
BCE
$21.7B
| $640K | ﹤0.01% |
15,108
-1,000
| -6% | -$44.6K |
|
1866
Brixmor Property Group
BRX
$9.21B
| $640K | ﹤0.01% |
+24,100
| New | +$629K |
|
1867
Sinclair Inc
SBGI
$1.03B
| $638K | ﹤0.01% |
20,310
+2,700
| +15% | +$73.4K |
|
1868
InterDigital
IDCC
$8.88B
| $637K | ﹤0.01% |
12,560
-1,600
| -11% | -$83K |
|
1869
H.B. Fuller
FUL
$3.24B
| $636K | ﹤0.01% |
14,840
| – | – |
|
1870
Insperity
NSP
$2.05B
| $635K | ﹤0.01% |
24,300
| – | – |
|
1871
Rambus
RMBS
$10.8B
| $635K | ﹤0.01% |
50,500
+13,600
| +37% | +$160K |
|
|
VISN
1872
Vistance Networks Inc
VISN
$2.62B
| $634K | ﹤0.01% |
22,200
+6,600
| +42% | +$184K |
|
1873
Synchrony
SYF
$26.1B
| $634K | ﹤0.01% |
20,900
+5,200
| +33% | +$162K |
|
1874
Agree Realty
ADC
$9.34B
| $633K | ﹤0.01% |
19,200
+500
| +3% | +$16.6K |
|
1875
Take-Two Interactive
TTWO
$45.2B
| $632K | ﹤0.01% |
24,845
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.